# György Losonczy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gyorgy-losonczy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,506 |
| Field | Lung Cancer Research Studies |
| h-index | 46 |
| i10-index | 113 |
| Last Known Institution | Semmelweis University |
| OpenAlex ID | https://openalex.org/A5054842148 |
| ORCID iD | https://orcid.org/0000-0002-0211-5237 |
| Works | 372 |

## Researcher papers

- [First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer](https://scholariq.org/papers/first-line-atezolizumab-plus-chemotherapy-in-extensive-stage-small-cell-lung/)
- [Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/durvalumab-plus-platinum-etoposide-versus-platinum-etoposide-in-first-line/)
- [Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/durvalumab-with-or-without-tremelimumab-plus-platinum-etoposide-versus-platinum/)
- [Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/randomized-phase-iii-placebo-controlled-trial-of-carboplatin-and-paclitaxel-with/)
- [Sexual dimorphism in renal ischemia-reperfusion injury in rats: Possible role of endothelin](https://scholariq.org/papers/sexual-dimorphism-in-renal-ischemia-reperfusion-injury-in-rats-possible-role-of/)

## Researcher topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Semmelweis University](https://scholariq.org/institutions/semmelweis-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.